Ameritas Investment Partners’s Novo Nordisk NVO Stock Holding History

Ameritas Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-422	Closed	-$23.4K	–	3160
2025 Q3	$23.4K	Hold	422	–	–	﹤0.01%	2588
2025 Q2	$29.1K	Hold	422	–	–	﹤0.01%	2494
2025 Q1	$29.3K	Hold	422	–	–	﹤0.01%	2389
2024 Q4	$36.3K	Sell	422 -300	-42%	-$32.4K	﹤0.01%	2368
2024 Q3	$86K	Hold	722	–	–	﹤0.01%	1887
2024 Q2	$103K	Buy	722 +300	+71%	+$39.8K	﹤0.01%	1701
2024 Q1	$54.2K	Hold	422	–	–	﹤0.01%	2104
2023 Q4	$43.7K	Hold	422	–	–	﹤0.01%	2248
2023 Q3	$38.4K	Hold	422	–	–	﹤0.01%	2239
2023 Q2	$34.1K	Hold	422	–	–	﹤0.01%	2269
2023 Q1	$33.6K	Hold	422	–	–	﹤0.01%	2216
2022 Q4	$28.6K	Buy	+422	New	+$24.7K	﹤0.01%	2387
2020 Q4	–	Sell	-664	Closed	-$23K	–	3099
2020 Q3	$23K	Buy	+664	New	+$22.1K	﹤0.01%	2304
2018 Q1	–	Sell	-1,140	Closed	-$3K	–	2962
2017 Q4	$3K	Hold	1,140	–	–	﹤0.01%	2915
2017 Q3	$27K	Hold	1,140	–	–	﹤0.01%	2256
2017 Q2	$24K	Hold	1,140	–	–	﹤0.01%	2357
2017 Q1	$19K	Sell	1,140 -1,030	-47%	-$17.9K	﹤0.01%	2436
2016 Q4	$38K	Hold	2,170	–	–	﹤0.01%	1134
2016 Q3	$45K	Hold	2,170	–	–	﹤0.01%	1103
2016 Q2	$58K	Hold	2,170	–	–	﹤0.01%	1026
2016 Q1	$58K	Hold	2,170	–	–	﹤0.01%	1021
2015 Q4	$63K	Buy	2,170 +1,140	+111%	+$31.6K	﹤0.01%	1008
2015 Q3	$27K	Hold	1,030	–	–	﹤0.01%	1028
2015 Q2	$28K	Buy	+1,030	New	+$29K	﹤0.01%	1077

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameritas Investment Partners's NVO Position: Q4 2025 in Review

Ameritas Investment Partners sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 422 shares — an estimated $23.4K sold.

Ameritas Investment Partners first reported a position in NVO in Q2 2015 and held it in 24 quarters. The position peaked at $103K in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Ameritas Investment Partners reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Ameritas Investment Partners sold 422 Novo Nordisk shares in Q4 2025, an estimated $23.4K.
Ameritas Investment Partners first reported a position in Novo Nordisk in Q2 2015 and held it in 24 quarters.
Ameritas Investment Partners's Novo Nordisk position peaked at $103K in Q2 2024.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.